[1]冉玉.消溃愈疡汤联合艾迪莎治疗溃疡性结肠炎50例[J].西部中医药,2013,26(03):101-102.
 RAN Yu.XiaoKui YuYangTang and Etiasa in Treating 50 Cases of Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2013,26(03):101-102.
点击复制

消溃愈疡汤联合艾迪莎治疗溃疡性结肠炎50例
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
26
期数:
2013年03期
页码:
101-102
栏目:
报道·衷中参西
出版日期:
2013-03-15

文章信息/Info

Title:
XiaoKui YuYangTang and Etiasa in Treating 50 Cases of Ulcerative Colitis
文章编号:
1004-6852(2013)03-0101-02
作者:
冉玉
兰州市七里河区黄峪乡卫生院,甘肃 兰州 730050
Author(s):
RAN Yu
Huangyu Township Health Center in Qilihe District of Lanzhou Municipality, Lanzhou 730050, China
关键词:
结肠炎溃疡性艾迪莎消溃愈疡汤内服灌肠
Keywords:
colitis ulcerative etiasa XiaoKui YuYangTang oral enema
分类号:
R632.1
文献标志码:
B
摘要:
目的:观察消溃愈疡汤内服、灌肠联合艾迪莎内服治疗溃疡性结肠炎的临床疗效。方法:将符合病例入选标准的 100 例溃疡性结肠炎患者按就诊的先后顺序随机分为观察组、对照组各 50 例。2 组患者入院后即嘱饮食以柔软、易消化、富含营养、富含维生素为主,对于有贫血、脱水症状者给予输血、输液等对症治疗,同时予艾迪莎,1.0 g/ 次,4 次 /d。观察组在此基础上予自拟消溃愈疡汤灌肠,1 剂 /d,早、晚各 1 次。2 组均以1 周为 1 个疗程,治疗 2 个疗程后观察疗效。结果:观察组治愈率为 76.00%,总有效率为 96.00%。对照组治愈率为 60.00%,总有效率为 82.00%。2 组治愈率、总有效率相比,差异有统计学意义(P<0.05)。2 组治疗后腹痛、腹泻、脓血便等症状积分较治疗前均明显降低(P<0.05),且治疗组降低较对照组更明显(P<0.05)。2 组不良反应发生率相比,差异有统计学意义(P<0.05)。结论:消溃愈疡汤内服、灌肠联合艾迪莎内服治疗溃疡性结肠炎疗效显著,可迅速改善症状、体征,且不良反应低。
Abstract:
Objective: To verify clinical effects of XiaoKui YuYangTang for enema and oral etiasa in treating ulcerative colitis. Method: One hundred patients were randomized into the observation group and the control group according to the sequences of visit, 50 cases each group. Both groups were put on soft, digestible and nutritive diet enriched of vitamin and given with corresponding treatment for anemia and dehydration. The observation group received XiaoKui YuYangTang for enema, one dose each day and twice per day. One course of treatment was one week, clinical effects were observed after two courses of treatment. Result: Cure rate and total effective rate of the observation group were 76.00% and 96.00%, higher than 60.00% and 82.00% of the control group with the difference, which demonstrated statistical meaning (P< 0.05). Symptom scores of both groups were lowered after treating than before treating in abdominal pain, diarrhea, bloody purulent stool and others (P< 0.05), and the observation group decreased greater than the control group (P< 0.05). Comparison between both groups in incidences of adverse reaction showed the difference and it had statistical meaning (P< 0.05). Conclusion: XiaoKui YuYangTang for enema and oral etiasa show notable effects in treating ulcerative colitis, which could improve symptoms and body signs with fewer adverse reactions.

参考文献/References:

[1] 陈灏珠.实用内科学[M].12 版.北京:人民卫生出版社,2006:1914-1916. [2] 全国慢性非感染性肠道疾病学术研讨会.溃疡性结肠炎的诊断及疗效标准[M].中华消化杂志,1993,13(6):354. [3] 张德正.溃疡性结肠炎的临床治疗与分析[J].中国现代医生,2007,45(8):37,89. [4] 王晓,刘凡.艾迪莎与柳氮磺胺吡啶治疗溃疡性结肠炎的近期疗效比较[J].中外医疗,2008,27(18):115-116. [5] 吴新宇,姜爱芳.艾迪莎治疗溃疡性结肠炎 126 例临床疗效观察[J].中国实用医药,2009,4(5):160. [6] 刘允.艾迪莎灌肠治疗溃疡性结肠炎 40例疗效观察[J].中国误诊学杂志,2006,6(9):1710-1711. [7] 赵永玲.艾迪莎加药物灌肠联合治疗溃疡性结肠炎 20 例临床观察[J].中国医药指南,2008,6(15):110-111. [8] 王翼洲,刘应东.热瘀散治疗轻中度溃疡性结肠炎 84 例[J].西部中医药,2012,25(4):66-68.

相似文献/References:

[1]黄文静.猴耳环消炎颗粒治疗婴幼儿过敏性结肠炎40例[J].西部中医药,2019,32(06):80.
 HUANG Wenjing.Treating 40 Cases of Infantile Allergic Colitis with HouErHuan XiaoYan Granules[J].Western Journal of Traditional Chinese Medicine,2019,32(03):80.
[2]武颜荣,阚存玲.固本益肠片联合美沙拉嗪片治疗中重度溃疡性结肠炎19例*[J].西部中医药,2013,26(01):79.
 WU Yanrong,KAN Cunling.Clinical Observation on GuBen Y iChang Tablets and Mesalazine Tablets in Treating Moderate and Severe Ulcerative Colitis:A Report of 19 Cases[J].Western Journal of Traditional Chinese Medicine,2013,26(03):79.
[3]景姗,王新月,杨雪,等.溃疡性结肠炎大鼠肺、肠组织中TGF-β1、SP-A表达的改变及中药的干预作用*[J].西部中医药,2014,27(03):10.
 JING Shan,WANG Xinyue,YANG Xue,et al.The Expressions of TGF-β1 and SP-A in the Lung and the Intestines of Rats with Ulcerative Colitis and TCM Intervention on the Changes[J].Western Journal of Traditional Chinese Medicine,2014,27(03):10.
[4]张艳.初发与复发溃疡性结肠炎院外治疗依从性的调查与分析[J].西部中医药,2017,30(02):58.
 ZHANG Yan.Investigation and Analysis of Extramural Hospital Treatment Compliance of Incipient and Relapse Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2017,30(03):58.
[5]丁永福.健脾清肠汤治疗脾虚湿热型溃疡性结肠炎40例[J].西部中医药,2018,31(02):88.
 DING Yongfu.JianPi QingChang Decoction in Treating 40 Cases of Ulcerative Colitis of Spleen-deficiency Damp-heat Pattern[J].Western Journal of Traditional Chinese Medicine,2018,31(03):88.
[6]何永成,马国杰.中医分期治疗溃疡性结肠炎43例[J].西部中医药,2018,31(08):81.
 HE Yongcheng,MA Guojie.TCM Phased Therapy in Treating 43 Cases of Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2018,31(03):81.
[7]杨薇薇.SASP加中药保留灌肠治疗溃疡性结肠炎64例[J].西部中医药,2019,32(01):102.
 YANG Weiwei.Treating 64 Cases of Ulcerative Colitis by SASP and Herbal Retention Enema[J].Western Journal of Traditional Chinese Medicine,2019,32(03):102.
[8]陈步强,常忠生,指导:陆金根.陆金根教授治疗轻中度溃疡性结肠炎学术思想探析[J].西部中医药,2020,33(02):47.[doi:10.12174/j.issn.1004-6852.2020.02.13]
 CHEN Buqiang,CHANG ZhongshengDirector: LU Jingen.Professor Lu Jingen′s Academic Thinking of Treating Mild - to - moderate Ulcerative Colitis[J].Western Journal of Traditional Chinese Medicine,2020,33(03):47.[doi:10.12174/j.issn.1004-6852.2020.02.13]
[9]沈照峰,朱磊,刘亚军,等.基于德尔菲法的溃疡性结肠炎患者相关危险因素调查分析[J].西部中医药,2020,33(04):82.[doi:10.12174/j.issn.1004-6852.2020.04.25]
 SHEN Zhaofeng,ZHU Lei,LIU Yajun,et al.An Investigation into the Related Risk Factors of UC Patients Based on Delphi Method[J].Western Journal of Traditional Chinese Medicine,2020,33(03):82.[doi:10.12174/j.issn.1004-6852.2020.04.25]
[10]杨洁,施丽婕.化瘀通阳方对溃疡性结肠炎大鼠IL-23/JAK-STAT信号通路的影响[J].西部中医药,2021,34(04):17.[doi:10.12174/j.issn.2096-9600.2021.04.05]
 YANG Jie,SHI Lijie.Effects of Stasis-resolving Yang-activating Prescription on IL-23/JAK-STAT Signaling Pathway in UC Rats[J].Western Journal of Traditional Chinese Medicine,2021,34(03):17.[doi:10.12174/j.issn.2096-9600.2021.04.05]

备注/Memo

备注/Memo:
收稿日期:2012-10-05 作者简介:冉玉(1967—),女,主治医师。研究方向:妇科常见病的中西医结合诊治。
更新日期/Last Update: 2013-03-15